Sign in

    David Tobias

    Board
    Since January 9, 2019
    Age
    72 years
    Tenure
    Joined the company as a director in 2014, assumed the role of President on 03-29-2016, was appointed CEO on 01-09-2019, and later took on the CFO role in Q4 2022.

    About

    David Tobias has built an extensive career in the cannabis industry, working in progressively responsible roles. He began his career as a Sales Manager for a custom builder before moving into executive roles, including Vice President at Medical Marijuana Inc. and President at Hemp, Inc. and Wild Earth Naturals, Inc..

    He joined CBDS as a director in 2014 and later assumed higher responsibilities within the company. On 03-29-2016 he joined as President and was promoted to CEO on 01-09-2019, eventually also serving as CFO in Q4 2022. His leadership and strategic vision have been instrumental during periods of significant change within the organization.

    Beyond his roles at CBDS, his career reflects a dedicated involvement in merging business strategies and operational improvements across multiple cannabis companies. His expertise in executive leadership and entrepreneurial experience has contributed to guiding the company through pivotal transitions, underscoring a professional journey marked by adaptability and forward-thinking management.

    $CBDS Performance Under David Tobias

    Past Roles

    OrganizationRoleDate RangeDetails
    Cannabis Sativa, Inc. Chief Financial Officer (CFO) 4th fiscal quarter 2022 Held prior to becoming CEO
    Cannabis Sativa, Inc. President March 29, 2016 - January 9, 2019 Former role before CEO appointment
    Cannabis Sativa, Inc. Director 2014 - Prior to CEO appointment N/A
    Wild Earth Naturals, Inc. President Since May 2013 - Pre-CBDS N/A
    Hemp, Inc. President August 2011 - January 9, 2014 N/A
    Medical Marijuana Inc. Vice President October 2009 - May 2011 Played a key role in facilitating the merger between CannaBank and Medical Marijuana, Inc.
    Xcite Homes Sales Manager October 2008 - August 2009 Tulsa custom builder

    External Roles

    OrganizationRoleDate RangeDetails
    THC Pharmaceuticals Inc. Director N/A Ticker: CBDG

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Salary$178,125 AnnualStandard fixed annual salary
    Stock Awards$0 N/ANo stock awards reported
    Director Fees$18,750 AccruedAccrued as stock payable
    Consulting Fees$187,500 AccruedAccrued for consulting services
    Notes Payable$47,920 principal + $13,779 interest Due December 31, 2023Loaned amount: $38,400 originally; Outstanding balance at Dec 31, 2023: $47,920; Interest accrued: $13,779; 5% per annum rate

    Performance Compensation

    Data from  FY 2023

    No information available on performance compensation for 2023